AC Immune SA
ACIU
Market Cap$198.88M
Close$
$-1.99
196.3% downside
Current Fair Value
196.3% downsideOvervalued by 196.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $198.88 Million |
|---|---|
| Enterprise Value | $268.77 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.51 |
| Beta | 1.58 |
| Outstanding Shares | 100,408,779 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.1 |
|---|---|
| PEG | -47.38 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 9.5 |
| Enterprise Value to EBIT | -5.36 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.33 |
| Debt to Equity | 0.95 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About AC Immune SA
CEO: Andrea Pfeifer